Satralizumab represents a potential new approach to treating neuromyelitis optica spectrum disorder (NMOSD), a rare, debilitating disease often misdiagnosed as multiple sclerosis (MS)… Click here…
Press
September 12, 2019 | Beverly Hills, CA — Genentech, a member of the Roche Group, announced positive results from one of its phase III clinical…
The 46-year-old woman suddenly felt too weak to stand. She slowly lowered herself to her kitchen floor. She’d been vomiting for the past five weeks,…
Featured Videos
Kathy Najimy interviews Victoria Jackson
Kathy Najimy: Hi, I’m Katie Couric, that’s a lie. I’m lying, I am Diane Sawyer. What? No, I’m lying again. I am Kathy Najimy and…
Hope with Kathy Najimy Part 3
Kathy Najimy: You’re giving some hope to this condition. Like I said before when I went to your first symposium, that was the thing that…
The Foundation with Kathy Najimy Part 2
Kathy Najimy: How did you reach the scientist and doctors? I would know my doctor, my friend Robin’s doctor and maybe one other. How did…
Ali’s Story with Kathy Najimy Part 1
Kathy Najimy: Hi, I’m Katie Couric. That’s a lie. I’m lying. I am Diane Sawyer. What? No, I’m lying again. I am Kathy Najimy, and…